cbdMD (YCBD) Cash & Equivalents (2016 - 2025)

cbdMD (YCBD) has 10 years of Cash & Equivalents data on file, last reported at $3.4 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents rose 71.96% year-over-year to $3.4 million; the trailing twelve-month figure through Dec 2025 stood at $3.4 million (up 71.96% YoY), and the FY2025 full-year result was $2.3 million, down 7.8% from the prior year.
• Cash & Equivalents grew to $3.4 million in Q4 2025, from $2.3 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $26.4 million in Q3 2021 to a low of $1.1 million in Q2 2025.
• A 5-year average of $7.4 million and a median of $2.6 million in 2023 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents soared 78.16% in 2021 and sank 87.11% in 2023, its largest moves.
• Tracing YCBD's Cash & Equivalents over 5 years: stood at $19.7 million in 2021, then tumbled by 82.98% to $3.4 million in 2022, then sank by 55.11% to $1.5 million in 2023, then soared by 30.92% to $2.0 million in 2024, then soared by 71.96% to $3.4 million in 2025.
• Business Quant data shows YCBD's Cash & Equivalents at $3.4 million in Q4 2025, $2.3 million in Q3 2025, and $1.1 million in Q2 2025.